Multiple endocrine neoplasia type 2 differential diagnosis: Difference between revisions
Irfan Dotani (talk | contribs) No edit summary |
Usama Talib (talk | contribs) |
||
| Line 7: | Line 7: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
Multiple endocrine neoplasia type 2 must be differentiated from the following hereditary diseases. | Multiple endocrine neoplasia type 2 must be differentiated from the following hereditary diseases.<ref name ="Men type 2" {{Cite journal| author = [[Jessica Marquard]] & [[Charis Eng]] | ||
| title = Multiple Endocrine Neoplasia Type 2 | |||
| year = 1993 | |||
| month = | |||
| pmid = 020301434 | |||
}}</ref> | |||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 60%" align=center | {| style="border: 0px; font-size: 90%; margin: 3px; width: 60%" align=center | ||
|valign=top| | |valign=top| | ||
| Line 38: | Line 43: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |An [[autosomal dominant]] genetic disorder causing [[tumor]]s of [[parathyroid]], [[pancreas]], and [[pituitary gland]]. | | style="padding: 5px 5px; background: #F5F5F5;" |An [[autosomal dominant]] genetic disorder causing [[tumor]]s of [[parathyroid]], [[pancreas]], and [[pituitary gland]]. | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" colspan="2"|<small>Adapted from Marquard J, Eng C. Multiple Endocrine Neoplasia Type 2. 1999 Sep 27 [Updated 2015 Jun 25]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1257/<ref | | style="padding: 5px 5px; background: #F5F5F5;" colspan="2"|<small>Adapted from Marquard J, Eng C. Multiple Endocrine Neoplasia Type 2. 1999 Sep 27 [Updated 2015 Jun 25]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1257/<ref name ="Men type 2" {{Cite journal| author = [[Jessica Marquard]] & [[Charis Eng]] | ||
| title = Multiple Endocrine Neoplasia Type 2 | | title = Multiple Endocrine Neoplasia Type 2 | ||
| year = 1993 | | year = 1993 | ||
Revision as of 16:05, 5 October 2017
|
Multiple endocrine neoplasia type 2 Microchapters |
|
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Multiple endocrine neoplasia type 2 differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 differential diagnosis |
|
FDA on Multiple endocrine neoplasia type 2 differential diagnosis |
|
CDC on Multiple endocrine neoplasia type 2 differential diagnosis |
|
Multiple endocrine neoplasia type 2 differential diagnosis in the news |
|
Blogs on Multiple endocrine neoplasia type 2 differential diagnosis |
|
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
|
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Multiple endocrine neoplasia type 2 must be differentiated from other hereditary tumors such as medullary thyroid carcinoma, C-cell hyperplasia, pheochromocytoma, von Hippel Lindau syndrome, hereditary paraganglioma-pheochromocytoma, polycythemia and paraganglioma/pheochromocytoma syndrome, neurofibromatosis type 1, and multiple endocrine neoplasia type 1 (MEN 1).
Differential Diagnosis
Multiple endocrine neoplasia type 2 must be differentiated from the following hereditary diseases. |}